L-Dopa and Behavior by Kebabian, John
BOOK REVIEWS 69
to include the "why" of procedures, but rather presents step-by-step instructions
and recipes for the bench technologist.
The first of the three sections deals with biochemical identification tests, from
acetate utilization to Voges-Proskauer. Each includes descriptions of purpose, prin-
ciple, mechanisms, equipment and reagents, method, and interpretation. The format
is short, lucid, and informative, leaving no need for guesswork. The text in this
section and in the other two is laced with almost 600 authoritative references for
the interested reader.
The second section is entitled "Procedures00 and includes excellent descriptions
of agglutinations, typings, culture methods, tyndallization, quantitative techniques,
and antimicrobial susceptibility testing. In the final section the use of a dozen differ-
ent staining methods and the preparation of more than 20 varieties of stains and
solutions are detailed.
Dr. Branson's manual is a unique and valuable asset to the abundant literature
in microbiology as a definitive source of tests and procedures. Undoubtedly, the
largest single source of methods today comes from the manufacturers of laboratory
reagents and equipment themselves. These are invariably either unreadable and
unworkable tomes or oversimplified and nonspecific primers. Similar practical ma-
terial may be found in many current volumes, but it usually suffers in clarity and
exactness by nature of many authors' attempts at a "broad-spectrum" approach
to the entire subject-i.e., bacterial agents, etiologies, clinical diagnosis, bacterio-
logic diagnosis, and treatment modalities.
Methods in Clinical Bacteriology remains true to its premise and while it will
not teach bacteriology, in the hands of a technician experienced in the ways of
differential bacteriologic diagnosis it will prove valuable.
ANDREW MAYRER
Third Year Medical Student
Yale University School of Medicine
L-DOPA AND BEHAVIOR. Edited by Sidney Malitz. Raven Press, New York, 414
pages; $9.75.
A variety of evidence has accumulated which indicates that dopamine is im-
portant in the physiology of the vertebrate nervous system. Norepinephrine, a puta-
tive neurotransmitter in the vertebrate brain, is directly synthesized from dopamine.
Dopamine, however, is also present in nerve terminals in several regions of the
vertebrate brain where little or no norepinephrine occurs. One such region is the
corpus striatum where there is much more dopamine than there is norepinephrine.
Recently it has been proposed that Parkinson's disease (paralysis agitans) can re-
sult from the depletion of this striatal dopamine. Furthermore, the administration
of large doses of L-dihydroxyphenylalanine (L-DOPA), the immediate metabolic
precursor of dopamine, often produces a dramatic reversal of the symptoms of
Parkinson's disease. The presumed biochemical mechanism for this action is the
conversion of the L-DOPA into dopamine within the corpus striatum.
The biochemical mechanisms by which dopamine affects the physiology of the
nervous system are only beginning to be elucidated. L-Dopa and Behavior is a
series of essays (actually presentations at a conference; both the date and the loca-
tion of this conference are not specified in the book) which present the results70 BOOK REVIEWS
of both basic and clinical research related to dopamine, L-DOPA and the func-
tioning of the nervous system. The presentations in this volume are related pre-
dominantly to clinical studies of the consequences of the administration of large
amounts of L-DOPA (18 of the 19 contributors are physicians). A significant per-
centage of the patients receiving L-DOPA for symptomatic relief from Parkinson's
disease develop undesirable behavioral disturbances which, according to Duvoisin
and Yahr (p. 68), "in general . resemble those produced by amphetamines."
Because of this effect of L-DOPA upon human behavior, a number of investigators
have utilized L-DOPA in the treatment of depression (a classification of behavior
which occurs frequently in this volume, although it was infrequently defined). Ac-
cording to Drs. Bunney, Goodwin, and Murphey (p. 100), "L-Dopa is not effective
in relieving depression." The other presentations vary widely in their scope, cov-
ering such topics as "mental function" (Dr. Barbeau) and "mood and depression"
(Dr. Everett). These discussions are highly speculative interpretations of the au-
thors' own results and the results of other investigators. In contrast to the latter
two reports, Drs. Snyder, Horn, Taylor, and Coyle directly present large amounts
of their own data, related to catecholamine uptake.-
This book may possess some interest, either for those concerned with the his-
torical status of research into behavioral effects of L-DOPA at some unspecified
time prior to the year 1972, or for those interested in the behavioral phenomena
after administration of large quantities of L-DOPA to people afflicted with Parkin-
son's disease and a variety of other, less well-defined, mental disorders. Those
readers concerned with the biochemical and physiological etiologies of these be-
havioral phenomena will be disappointed by the vagueness of the discussions in
this volume.
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